Xencor Inc . (NASDAQ:XNCR), a biopharmaceutical company specializing in innovative therapies for immunology and oncology, ...

The research team, studying the efficacy of a preventive antibody-based therapy, found it successfully protects monkeys from ...

The test, which runs on the Swiss company's high-throughput MosaiQ System, detects 15 different autoantibodies.

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

A recent study showed limited data exist on the risks associated with anti-G during pregnancy, including the development of ...

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

AliveDx’s CE mark for the systematic autoimmune rheumatic disease (SARD) assay marks its fifth approval in the past 18 months ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

Media ReleaseMarking Immutep’s transition to a Phase III biotech, the Company’s pivotal TACTI-004 trial in first-line non-small cell lung cancer ...

Novartis has finally given up on iscalimab after deciding that the anti-CD40 antibody is not worth pursuing in Sjögren’s syndrome. | Novartis has finally given up on iscalimab after deciding that the ...

Scientists found that a moderate dose of MEDI8852, an antibody therapy, effectively protected monkeys against severe H5N1 avian flu.